Similar articles

• Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.

  Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, De Franco S, Brini M, Sgarbi G, Lodi R. Paci M, et al. Lung Cancer. 2009 Apr;64(1):92-7. doi: 10.1016/j.lungcan.2008.07.012. Epub 2008 Sep 19. Lung Cancer. 2009. PMID: 18804892
• Early detection of lung cancer using serum RNA or DNA markers: ready for "prime time" or for validation?

  Bunn PJ Jr. Bunn PJ Jr. J Clin Oncol. 2003 Nov 1;21(21):3891-3. doi: 10.1200/JCO.2003.07.976. Epub 2003 Sep 24. J Clin Oncol. 2003. PMID: 14507944 Review. No abstract available.
• Quantification of free circulating DNA as a diagnostic marker in lung cancer.

  Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA, Pastorino U. Sozzi G, et al. J Clin Oncol. 2003 Nov 1;21(21):3902-8. doi: 10.1200/JCO.2003.02.006. Epub 2003 Sep 24. J Clin Oncol. 2003. PMID: 14507943
• Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.

  Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, Wang YC. Hsu HS, et al. Cancer. 2007 Nov 1;110(9):2019-26. doi: 10.1002/cncr.23001. Cancer. 2007. PMID: 17876837
• Circulating tumour-derived predictive biomarkers in oncology.

  Hodgson DR, Wellings R, Orr MC, McCormack R, Malone M, Board RE, Cantarini MV. Hodgson DR, et al. Drug Discov Today. 2010 Feb;15(3-4):98-101. doi: 10.1016/j.drudis.2009.12.006. Epub 2010 Jan 4. Drug Discov Today. 2010. PMID: 20045486 Review.